Statewide

The Innovation Award honors breakthrough product development that significantly improves election verification and auditing. The program provides hands-on training and unmatched real-world experience.

Luna Labs USA, LLC, a product development company accelerating breakthrough solutions will invest $200,000 to expand its operations in the City of Charlottesville. The company will create 20 new jobs.

Esser will work with scientists to accelerate the development of new medicines and treatments for illnesses like cancer and Alzheimer's.

One of Esser's responsibilities will be to foster an "ecosystem of innovation" that will attract biotechnology and pharmaceutical companies to Central Virginia and the greater Commonwealth.

The Commonwealth BioAccelerator officially opened its doors, transforming 6,500 square feet of cutting-edge lab space into a launchpad for Virginia's most promising biotech ventures.

CvilleBioHub, a regional, industry-led organization, received a $4.3 million GO Virginia award and is partnering with UVA to establish the region's first laboratory accelerator at North Fork.

As part of the new institute, UVA's Biocomplexity Institute (BI) is contributing innovative AI research and solutions that will bolster efforts to detect illicit financial activity and address vulnerabilities within global supply chains.

The plant in Chesterfield County, Virginia, is the result of university-generated knowledge and sustained basic research. UVA faculty are engaged in a Fusion Innovation Hub to build out the ecosystem.

A statewide biopharma boom is fueled by talent emerging from Virginia's universities, which provide a steady pipeline of specialized labor.

The Office of the Director of National Intelligence was the catalyst for the institute, with the goal of using next-gen technology to identify potential security threats and protect Americans.

The Virginia Catalyst Fund encourages collaboration with over 30 industry partners in collaboration with Virginia universities, including UVA.

The UVA Manning Institute of Biotechnology positions UVA at the very forefront of cutting-edge medicine, such as cellular and gene therapies that revolutionize how diseases are treated and cured.